VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
NCT ID: NCT02156401
Last Updated: 2024-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2013-04-30
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
VTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE).
The standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
NCT02155491
An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in Taiwan
NCT03799016
Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism
NCT04124159
Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
NCT04439383
Observational Prospectif Monocentric Registry of Patients Suffering From VIE
NCT02188056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1: Suspect of Pulmonary Embolism (PE)
No interventions assigned to this group
Cohort 2: Suspect of Deep Vein Thrombosis (DVT)
No interventions assigned to this group
Cohort 3: Incidental Venous Thromboembolism (VTE)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical condition:
* Cohort 1: Clinical suspicion of acute PE (with or without DVT)
* Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE)
* Cohort 3: Incidentally diagnosed VTE
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University
OTHER
Hochschule Fresenius
OTHER
University of Bonn
OTHER
Siemens Corporation, Corporate Technology
INDUSTRY
Bayer
INDUSTRY
Eurofins
INDUSTRY
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philipp Wild, MD, MSc
Univ.-Prof. Dr. med. Philipp Wild, MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp S Wild, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
University Medical Center of Johannes Gutenberg University Mainz, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center of the Johannes Gutenberg University Mainz
Mainz, Rhineland-Palatinate, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Ten Cate V, Eggebrecht L, Schulz A, Panova-Noeva M, Lenz M, Koeck T, Rapp S, Arnold N, Lackner KJ, Konstantinides S, Espinola-Klein C, Munzel T, Prochaska JH, Wild PS. Isolated Pulmonary Embolism Is Associated With a High Risk of Arterial Thrombotic Disease: Results From the VTEval Study. Chest. 2020 Jul;158(1):341-349. doi: 10.1016/j.chest.2020.01.055. Epub 2020 Mar 23.
Frank B, Ariza L, Lamparter H, Grossmann V, Prochaska JH, Ullmann A, Kindler F, Weisser G, Walter U, Lackner KJ, Espinola-Klein C, Munzel T, Konstantinides SV, Wild PS; VTEval study group. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project. BMJ Open. 2015 Jul 1;5(7):e008157. doi: 10.1136/bmjopen-2015-008157.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMCM-2013EPI02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.